drugset / Trial / NCT00736528

A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers

NCT00736528

Phase 1 Terminated 10 enrolled Pfizer
RandomizedParallel-groupDouble-blind

Summary

To describe the safety, tolerability and pharmacokinetics of PF-04447943 after administration of multiple, ascending, oral doses to healthy elderly subjects.

Timeline

Start
2008-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject EDELINONTRINE Small molecule 5 mg Oral
Subject EDELINONTRINE Small molecule 15 mg Oral
Subject EDELINONTRINE Small molecule 45 mg Oral

Indications

No indication recorded.